164 related articles for article (PubMed ID: 22744232)
1. The cardioprotective effects of an antiemetic drug, tropisetron, on cardiomyopathy related to doxorubicin.
Alimoradi H; Barzegar-Fallah A; Hassanzadeh G; Mohammadi-Rick S; Asadi F; Delfan B; Abbasi A; Dehpour AR
Cardiovasc Toxicol; 2012 Dec; 12(4):318-25. PubMed ID: 22744232
[TBL] [Abstract][Full Text] [Related]
2. Cardioprotective effect of whole fruit extract of pomegranate on doxorubicin-induced toxicity in rat.
Hassanpour Fard M; Ghule AE; Bodhankar SL; Dikshit M
Pharm Biol; 2011 Apr; 49(4):377-82. PubMed ID: 21391840
[TBL] [Abstract][Full Text] [Related]
3. Morphine is protective against doxorubicin-induced cardiotoxicity in rat.
Kelishomi RB; Ejtemaeemehr S; Tavangar SM; Rahimian R; Mobarakeh JI; Dehpour AR
Toxicology; 2008 Jan; 243(1-2):96-104. PubMed ID: 17988779
[TBL] [Abstract][Full Text] [Related]
4. The modulatory effect of lithium on doxorubicin-induced cardiotoxicity in rat.
Rahimi Balaei M; Momeny M; Babaeikelishomi R; Ejtemaei Mehr S; Tavangar SM; Dehpour AR
Eur J Pharmacol; 2010 Sep; 641(2-3):193-8. PubMed ID: 20534381
[TBL] [Abstract][Full Text] [Related]
5. Cardioprotective effect of grape-seed proanthocyanidins on doxorubicin-induced cardiac toxicity in rats.
Ammar el-SM; Said SA; El-Damarawy SL; Suddek GM
Pharm Biol; 2013 Mar; 51(3):339-44. PubMed ID: 23134235
[TBL] [Abstract][Full Text] [Related]
6. How to protect doxorubicin-induced cardiomyopathy in male albino rats?
Shaker O; Sourour DA
J Cardiovasc Pharmacol; 2010 Mar; 55(3):262-8. PubMed ID: 20051877
[TBL] [Abstract][Full Text] [Related]
7. Doxorubicin mediated cardiotoxicity in rats: protective role of felodipine on cardiac indices.
Gandhi H; Patel VB; Mistry N; Patni N; Nandania J; Balaraman R
Environ Toxicol Pharmacol; 2013 Nov; 36(3):787-95. PubMed ID: 23958971
[TBL] [Abstract][Full Text] [Related]
8. Cardioprotective Effect of Phenytoin on Doxorubicin-induced Cardiac Toxicity in a Rat Model.
Razmaraii N; Babaei H; Mohajjel Nayebi A; Asadnasab G; Ashrafi Helan J; Azarmi Y
J Cardiovasc Pharmacol; 2016 Mar; 67(3):237-45. PubMed ID: 26544684
[TBL] [Abstract][Full Text] [Related]
9. Cardiotoxicity of doxorubicin/paclitaxel combination in rats: effect of sequence and timing of administration.
Saad SY; Najjar TA; Alashari M
J Biochem Mol Toxicol; 2004; 18(2):78-86. PubMed ID: 15122649
[TBL] [Abstract][Full Text] [Related]
10. Cranberry (Vaccinium macrocarpon) protects against doxorubicin-induced cardiotoxicity in rats.
Elberry AA; Abdel-Naim AB; Abdel-Sattar EA; Nagy AA; Mosli HA; Mohamadin AM; Ashour OM
Food Chem Toxicol; 2010 May; 48(5):1178-84. PubMed ID: 20146931
[TBL] [Abstract][Full Text] [Related]
11. Protection against doxorubicin cardiomyopathy in rats: role of phosphodiesterase inhibitors type 4.
Mohamed HE; Asker ME; Ali SI; el-Fattah TM
J Pharm Pharmacol; 2004 Jun; 56(6):757-68. PubMed ID: 15231041
[TBL] [Abstract][Full Text] [Related]
12. Grape seed and skin extract protects against acute chemotherapy toxicity induced by doxorubicin in rat heart.
Mokni M; Hamlaoui-Guesmi S; Amri M; Marzouki L; Limam F; Aouani E
Cardiovasc Toxicol; 2012 Jun; 12(2):158-65. PubMed ID: 22290400
[TBL] [Abstract][Full Text] [Related]
13. Kaempferol protects against doxorubicin-induced cardiotoxicity in vivo and in vitro.
Xiao J; Sun GB; Sun B; Wu Y; He L; Wang X; Chen RC; Cao L; Ren XY; Sun XB
Toxicology; 2012 Feb; 292(1):53-62. PubMed ID: 22155320
[TBL] [Abstract][Full Text] [Related]
14. Amelioration of doxorubicin-induced cardiotoxicity by deferiprone in rats.
Ammar el-SM; Said SA; Suddek GM; El-Damarawy SL
Can J Physiol Pharmacol; 2011 Apr; 89(4):269-76. PubMed ID: 21526973
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of saponins from Panax notoginseng against doxorubicin-induced cardiotoxicity in mice.
Liu L; Shi R; Shi Q; Cheng Y; Huo Y
Planta Med; 2008 Feb; 74(3):203-9. PubMed ID: 18260050
[TBL] [Abstract][Full Text] [Related]
16. Antioxidant and anti-apoptotic effects of onion (Allium cepa) extract on doxorubicin-induced cardiotoxicity in rats.
Alpsoy S; Aktas C; Uygur R; Topcu B; Kanter M; Erboga M; Karakaya O; Gedikbasi A
J Appl Toxicol; 2013 Mar; 33(3):202-8. PubMed ID: 21996788
[TBL] [Abstract][Full Text] [Related]
17. Protection from doxorubicin-induced cardiomyopathy using the modified anthracycline N-benzyladriamycin-14-valerate (AD 198).
Cai C; Lothstein L; Morrison RR; Hofmann PA
J Pharmacol Exp Ther; 2010 Oct; 335(1):223-30. PubMed ID: 20668052
[TBL] [Abstract][Full Text] [Related]
18. Preventive cardioprotection of erythropoietin against doxorubicin-induced cardiomyopathy.
Chen X; Chen Y; Bi Y; Fu N; Shan C; Wang S; Aslam S; Wang PW; Xu J
Cardiovasc Drugs Ther; 2007 Oct; 21(5):367-74. PubMed ID: 17924179
[TBL] [Abstract][Full Text] [Related]
19. Doxorubicin-Induced Cardiac Abnormalities in Rats: Attenuation via Sandalwood Oil.
Younis NS
Pharmacology; 2020; 105(9-10):522-530. PubMed ID: 31747659
[TBL] [Abstract][Full Text] [Related]
20. Epigallocatechin-3-gallate pretreatment attenuates doxorubicin-induced cardiotoxicity in rats: A mechanistic study.
Saeed NM; El-Naga RN; El-Bakly WM; Abdel-Rahman HM; Salah ElDin RA; El-Demerdash E
Biochem Pharmacol; 2015 Jun; 95(3):145-55. PubMed ID: 25701654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
